Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.

Self-perceived stress among young women was significantly associated with increased risk for early-onset cryptogenic ischemic ...

(HealthDay News) — Self-perceived stress is associated with cryptogenic ischemic stroke (CIS), according to a study published online March 5 in Neurology.

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

Ischemic stroke is a fatal condition caused by an arterial embolism that blocks the blood flow through the cerebral artery, frequently being a cause of mortality and disability. Fibroblast growth ...

In the US, the rate of ischemic stroke among adults aged 20 to 44 surged from 17 per 100,000 adults in 1993 to 28 per 100,000 in 2015. The risk of stroke death among young adults is also on the rise.

Ali, H. , Ghaysaa, H. , Jaafar, W. and Malek, M. (2025) Ischemic Stroke Following Coronary Angiography: A Case Report. Case ...

Propranolol May Reduce Ischemic Stroke Risk in Women With Migraines Jan. 30, 2025 — Propranolol, a beta blocker medication used for treating high blood pressure and preventing migraines ...

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...

Ischemic stroke is a more common type of stroke and a leading cause of physical disability, cognitive decline, and death worldwide. Events occurring after an ischemic stroke episode determine the ...